Sepsis-associated encephalopathy by Cotena, Simona & Piazza, Ornella
Translational Medicine @ UniSa, - ISSN 2239-9747 2012, 2(3): 20-27 
 
20 




Simona Cotena1, Ornella Piazza2. 
1. Dipartimento di Scienze Chirurgiche 
Anestesiologiche Rianimatorie e dell'Emergenza, 
Università degli Studi di Napoli “Federico II”. 
2. Dipartimento di Anestesia e Rianimazione, 
Università degli Studi di Salerno. 
 
Summary 
Sepsis-associated encephalopathy (SAE) is defined 
as a diffuse or multifocal cerebral dysfunction 
induced by the systemic response to the infection 
without clinical or laboratory evidence of direct brain 
infection. 
Its pathogenesis is multifactorial. SAE generally 
occurs early during severe sepsis and precedes 
multiple-organ failure. 
The most common clinical feature of SAE is the 
consciousness alteration which ranges from mildly 
reduced awareness to unresponsiveness and coma. 
Diagnosis of SAE is primarily clinical and depends 
on the exclusion of other possible causes of brain 
deterioration. Electroencephalography (EEG) is 
almost sensitive, but it is not specific for SAE.  
Computed Tomography (CT) head scan generally is 
negative in case of SAE, while Magnetic Resonance 
Imaging (MRI) can show brain abnormalities in case 
of SAE, but they are not  specific for this condition. 
Somatosensitive Evoked Potentials (SEPs) are 
sensitive markers of developing cerebral dysfunction 
in sepsis. Cerebrospinal fluid (CBF) analysis is 
generally normal, a part an inconstant elevation of 
proteins concentration. 
S100B and NSE have been proposed like biomarkers 
for diagnosis of SAE, but the existing data are 
controversial. SAE is reversible even if survivors of 
severe sepsis have often long lasting or irreversible 
cognitive and behavioral sequel; however the 
presence of SAE can have a negative influence on 
survival. 
A specific therapy of SAE does not exist and the 
outcome depends on a prompt and appropriate 
treatment of sepsis as whole. 
Sepsis-associated encephalopathy; S100B; blood 
brain barrier; brain edema. 
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The brain is not, as once thought, a privileged organ 
protected by BBB, but it is strongly interconnected to 
the immune system and it is actively involved in the 
response to a noxious stimuli like an infection. 
As an example, we may think to a condition in which 
fever is present, the most simple and studied model 
of the inflammatory response of the brain. 
The term SAE is used to define a diffuse or 
multifocal cerebral dysfunction induced by the 
systemic response to the infection without clinical or 
laboratory evidence of direct brain infection (1).   
We shortly review SAE epidemiology, the main 
patho-physiologic theories, its clinical presentation, 
diagnosis, prognosis and the management. 
Pathogenesis of SAE 
SAE occurs in 9% to 71% of all critical ill patients 
suffering from sepsis (2). This wide range is due to 
the definition criteria extremely variable among the 
different Authors. 
The pathogenesis of SAE is unclear; several 
mechanisms have been proposed like possible causes 
of brain damage during severe sepsis: the direct 
bacterial invasion, the effect of endotoxins and of the 
inflammatory mediators, the BBB dysfunction and 
the CBF impairment, the alteration of amino acids 
and of neurotransmitters, apoptosis, oxidative stress 
and excitotoxicity, but the most accredited 
hypothesis is that pathogenesis of SAE is 
multifactorial. The following paragraphs discuss 
these possible mechanisms. 
Direct bacterial invasion 
Although in many cases of severe sepsis, a cerebral 
localization of micro-organisms had been described, 
the term SAE, instead of septic encephalopathy, 
stresses the concept that the brain impairment which 
often occurs in septic patients is independent from a 
direct cerebral infection. In fact, many cases of SAE 
without micro-abscesses have been observed and 
there is no correlation between SAE and a particular 
microorganism (3). So, it is unlikely that direct brain 
infection may play a causative role in SAE. 
Endotoxins 
Bacterial toxins and, in particular, LPS 
(lypopolisaccharide), are more likely one of the 
causes of brain dysfunction during sepsis. According 
to Sharshar LPS in high concentrations could act 
directly on the brain in the circumventricular organs 
which are not protected by the BBB. Here LPS 
would bind its receptors such as the Toll Like 
Receptor (TLR), inducing the synthesis of 
inflammatory cytokines, prostaglandines and Nitric 
Oxide (NO) from microglia and astrocytes. 
At low concentrations it would induce the peripheral 
secretion, from monocytes/macrophages, of 
inflammatory cytokines, among which IL-6 would 
directly act on the brain inducing the expression of 
mediators of the inflammation (4). 
Inflammatory mediators 
When an infection occurs, peripheral 
monocytes/macrophages respond with the secretion 
of inflammatory cytokines; among these IL-1, TNF-α 
and IL-6 seem to be the most important ones in 
mediating the cerebral response to infection. While 
IL-1 and TNF-α have a local action inducing IL-6 
production, this last one has endocrine properties and 
plays a key role in brain activation (3). In fact it is 
able to induce COX2 (cyclooxygenase 2) from glial 
cells and so the synthesis of prostaglandins and in 
particular of prostaglandin E2 which is responsible 
of the activation of hypothalamus pituitary adrenal 
axis (HPAA), of fever and of behavioral alterations 
(5). The activation of the complement cascade, 
particularly of the anaphylatoxin C5a, has been 
associated to brain dysfunction during sepsis, 
probably by inducing BBB break down (6). 
BBB dysfunction 
Both LPS and cytokines are able to induce an 
endothelial activation named panendothelitis. In fact, 
they induce the expression of adhesion molecules on 
brain microvessel endothelial cells; they also induce 
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the secretion of proinflammatory cytokines and of 
nitric oxide synthase (NOS). This endothelial 
activation results in increased permeability and 
disruption of BBB with consequent vasogenic brain 
edema. Furthermore, astrocytes endfeet surrounding 
cortical microvessels are frequently swollen and their 
membranes ruptured and detached from the 
microvessel walls. Astrocyte endfeet swelling is a 
direct consequence of the BBB breakdown; on the 
other hand, it may further impair BBB function in 
sepsis. Perimicrovessel edema impairs the movement 
of oxygen, nutrients and metabolites across the 
microvessel wall. 
As direct consequence of BBB dysfunction, the 
differential flux of chemical is altered in sepsis; 
aromatic amino acids are more readily transported 
than branched chain amino acids from blood to brain; 
this results in an increased ratio of aromatic to 
branched-chain amino acids in plasma (see below). 
Is not clear if the vasogenic edema found in MRI 
images of patients with SAE is the consequence of 
BBB disruption. In according to some Authors (7) 
some other mechanism might be involved in the 
formation of edema. Brain edema in SAE may be 
related to the loss of autoregulation rather than to 
BBB damage even if the initial vasogenic edema 
may evolve into cytotoxic edema (8). 
CBF and cerebrovascular autoregulation 
CBF decrease and brain ischemia have been 
considered possible causes of brain impairment 
during severe sepsis, even if cerebral dysfunction 
occurs also in absence of hemodynamic alterations. 
An impairment of CBF could be the consequence of 
microvascular alterations, which occur in other 
organs, rather than an effect of systemic hypotension. 
Several Authors measured CBF in septic patients, but 
the results are almost controversial; while some 
Authors found an effective decrease of CBF, other 
ones found it normal or increased (9 -10). 
Up to date, it is not clear if in patients with severe 
sepsis there is a loss of cerebral autoregulation and if 
it could may play a role in the pathogenesis of SAE 
(8). 
In a recent study by Szatmári and colleagues an 
impaired cerebral vasomotor reactivity studied by 
acetazolamide test was found. This reduced 
reactivity was attributed by the Authors to a 
vasoconstriction at the level of resistance arterioles 
due to many factors: the disruption of the BBB 
which allows the passage of endogenous 
cathecolamines; the inhibition of endothelial NOS by 
cytokines; microthromboses and microinfarctions 
resulting from the alteration of the coagulation 
system (11). 
Amino acids and Neurotransmitters imbalance 
In septic patients plasma an increased ratio of 
aromatic to branched-chain amino acids 
(AAA/BCAA) has been found. This is probably the 
consequence of the severe catabolic state which 
characterizes sepsis. In these conditions, in fact, there 
is an intense protheolysis with release in the plasma 
of both aromatic and branched-chain amino acids; 
these latter are used from the muscle for energy 
production. 
Systemic inflammation also causes an increase of the 
cerebral release and of the unidirectional influx of 
phenylalanine. The consequent increased arterial 
levels of this aminoacid may affect cerebral function 
by reducing the availability of BCAAs to the brain. 
In particular the reduction of the influx of leucine 
can impair excitatory neurotransmission. 
Furthermore, it has been demonstrated a net cerebral 
efflux of glutamine after LPS infusion, which 
probably reflects an its compensatory astrocytic 
release  in order to reduce osmotic stress, or an 
increased cerebral proteolysis (12).  
An imbalance of amino acid ratio has been shown 
even in the CSF and it is caused, like previously 
reported, by BBB dysfunction.  
An increase of serum concentration of gamma-
aminobutyric acid (GABA) has been proposed as 
alternative mechanism of brain dysfunction in sepsis, 
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but the data existing in literature are controversial 
(1). 
Mitochondrial dysfunction 
Mitochondrial dysfunction may be related to both the 
induction of neural cell apoptosis and an insufficient 
energy supply.  
A decrease in mitochondrial ATP generation is 
caused by cytokines, reactive oxygen species (ROS) 
and NO. On the other hand, mitochondria can induce 
neuronal apoptosis by releasing cytocrome C (13).  
Calcium homeostasis 
SAE is associated to an increase in intracellular 
calcium levels. This increase has been attributed to 
the ischemia, to the presence of excitatory amino-
acids or to a direct effect of cytokines. The alteration 
of calcium homeostasis impairs learning memory and 
cognitive function (13). 
In conclusion none of the described mechanism plays 
as an isolated causative mechanism of SAE but a 
multifactorial action should be verified. Moreover, 
the brain dysfunction during sepsis could be also 
attributed to metabolic disturbances caused by 
hepatic and/or renal failure, even if SAE generally 
precedes multi-organ failure.  
Hypoperfusion consequent to septic shock can also 
cause brain damage and the effect of the use of 
sedative drugs should be also considered as possible 
cause of neurological impairment, since drugs often 
show delayed clearance in sepsis. 
Anyway all the above mentioned conditions should 
be excluded before defining with the term of SAE a 
cerebral dysfunction which occurs in a septic patient. 
Clinical features 
SAE  generally occurs early during severe sepsis and 
precedes multiple-organ failure.  
The most common clinical feature of SAE is the 
consciousness alteration which ranges from mildly 
reduced awareness to unresponsiveness and coma. 
Fluctuating confusional states, inattention and 
inappropriate behavior are often present in mild 
encephalopathic patients, mainly early in the course 
of the clinical syndrome. In more severe cases 
patients may present delirium, agitation and then 
consciousness deterioration and coma. 
Some Authors use the term “delirium” instead of 
“encephalopathy” (14), but the two conditions are 
not synonymous since SAE is one of many causes of 
delirium, but delirium is not the only clinical 
presentation of SAE. Furthermore, symptoms of SAE 
can entirely bypass the stage of delirium (13). 
Motor signs are uncommon; asterixis, myoclonus 
and tremors, which are frequent in metabolic 
encephalopathies, are rare in SAE. Relatively more 
common is the presence of a paratonic rigidity, 
defined as a velocity-dependent resistance to passive 
movements, less evident when limbs are moved 
slowly. 
Seizures have been reported in SAE, but they are 
uncommon; cranial nerve dysfunction and 
lateralization are exceptional, and their presence 
require the exclusion of more frequent causes. 
Last, neuroendocrine dysfunction and autonomic 
failure, which characterize severe sepsis are often a 
consequence of brain dysfunction (1-3). 
GCS is used by many authors to describe cerebral 
impairment during sepsis, while the use of the 
Confusion Assessment Method for the Intensive Care 
Unit (CAM-ICU) is controversial (13-14). 
Diagnosis 
Instrumental findings 
Diagnosis of SAE is primarily clinical and depends 
on the exclusion of other possible causes of brain 
deterioration (metabolic or structural). 
EEG is almost sensitive and it can show 
abnormalities even when the neurological 
examination is normal (1). Young et al. identified 5 
classes of progressively worsened EEG pattern 
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related to worsened outcome: 1 = normal EEG, 2 = 
excessive theta, 3 = predominant delta, 4= triphasic 
waves, 5 = suppression or burst suppression, in 
ascending order of severity. Anyway it is not specific 
for SAE and it is often unavailable or unreliable for 
sedation or other metabolic derangement. 
CT head scan generally is negative in case of SAE, 
but it should be performed to exclude a 
hypoxic/ischemic brain damage. 
MRI can show brain abnormalities in case of SAE, 
but they are not specific for this condition. 
In a case report previously published, we reported 
four cases of SAE (8); in two out of these MRI was 
negative, while in the other two patients it showed 
images of vasogenic edema (table 1). These images, 
like above mentioned, are more easily related to the 
loss of cerebral auto-regulation than to BBB 
disruption.  
Bartinsky (15) reported 26 cases of PRES (posterior 
reversible encephalopathy syndrome) associated with 
isolate infection or sepsis. Fugate and colleagues 
identified 120 cases of PRES; in 7% of cases sepsis 
was the recognized cause. These patients had more 
often cortical involvement if compared to the other 
causes of PRES, and in all cases they had parieto-
occipital involvement. Endothelial dysfunction was 
identified as the possible pathogenetic mechanism of 
PRES in septic patients (16). Sharshar et al. (17) 
described, in a MRI study of septic shock, injuries of 
the white matter in the “border” regions, where the 
terminal vessels may be easily jeopardized, 
independently of specific BBB lesions. 
Anyway the cost of MRI and the complicated 
transport of the patients have been a limitation to its 
widespread use in the clinical management of sepsis. 
Zauner et al. registered SEPs in septic patients and 
observed an increase of their peak latencies in 
cortical and subcortical pathways. This impairment 
was associated with severity of illness but the results 
did not differ significantly between patients with 
severe sepsis and those with septic shock (18). 
Ohnesorge et al. registered SEPs in pigs with 
experimental systemic inflammatory response 
(SIRS): they observed an attenuation of amplitudes 
at least 4 hours before the hemodynamic SIRS 
criteria ensue. So SEPs can be considered like 
sensitive markers of developing cerebral dysfunction 
in SIRS (19). 
Cerebrospinal fluid analysis does not give definitive 
information in case of SAE since it is generally 
normal, apart of an inconstant elevation of protein 
concentration. However it could be useful to exclude 
meningitis in suspected cases. 
Table 1. S100B serum and liquoral levels, EEG and 
MRI in 4 cases of sepsis 
 Patient 1 Patient 2 Patient 3 Patient 4 
Serum  
S100 B  
(μg/l) 





























* not indicated 
Biomarkers 
The markers of cerebral damage have been proposed 
for diagnosis of SAE. Among these S100B and NSE 
have been the most studied. 
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S100B is a calcium binding protein produced in the 
central nervous system mainly – but not exclusively 
– by astroglial cells. Its increase in serum and in CSF 
after brain injury has been attributed to an active 
secretion from these cells, since it probably takes 
part in the inflammatory response of the brain. It has 
been proposed as indicator of adverse neurocognitive 
outcome following global cerebral ischemia and 
brain trauma and as diagnostic marker of brain 
tumors and of BBB disruption. 
NSE is the intracytoplasmatic glycolytic enzime 
enolase; it is found in neurons and neuroendocrine 
tissue and it is elevated in blood circulation after 
increase death rate of this cells. 
 Nguyen et al. (20) measured S100B and NSE in the 
serum of 170 patients with severe sepsis and septic 
shock. They found that both S100B and NSE 
increased and correlated with brain injury. S100B 
levels more closely reflected severe encephalopathy 
and type of brain lesions than NSE and GCS. 
In contrast with these results, we previously reported 
data about serum S100B measurement in 19 patients 
with severe sepsis excluding those with septic shock 
(21); even if the protein was increased in 56% of 
patients, it didn't correlate with the presence of SAE.  
Since S100B has poor ability to escape the tight 
junctions of the blood brain barrier, its increase in the 
serum has been attributed to an increased 
permeability of the BBB. In porcine endotoxemic 
shock, Larsson et al. (22) found increased serum 
levels of S100B, which were attributed to minor 
BBB damage caused by the endotoxin effect on glial 
cell integrity, even if the Authors cannot exclude the 
contribution of other cells. 
We observed in one patient normal CSF value of 
S100B with concomitant increased serum level; in 
this patient, serum origin of the protein is likely 
extracerebral and it cannot be attributed to alteration 




SAE is reversible even if survivors of severe sepsis 
have often long lasting or irreversible cognitive and 
behavioral sequel.  
However the presence of SAE can have a negative 
influence on survival. This probably is due to the fact 
that the brain is not an isolated organ, but actively 
participates and controls the main functions of the 
body. The brain dysfunction which can occur during 
severe sepsis does not cause only consciousness 
alterations but, like previously reported, also 
dysfunctions in neuroendocrine and autonomic 
systems which can negatively influence the 
prognosis in septic patients. 
Management 
At the moment a specific therapy of SAE does not 
exist; the outcome of patients depends on a prompt 
and appropriate treatment of sepsis as whole. 
Some Authors obtained encouraging results from 
administration of branched-chain amino acids (13).  
The blockade of C5a by administrating anti-C5a 
neutralizing antibodies , has been proposed, even if 
its real benefit is controversial (6, 23). 
It has been demonstrated that Ghrelin prevents 
cognitive impairment in SAE by reducing neuronal 
apoptosis (24). 
The use of Dotrecogin alpha has been suggested to 
reduce neuronal damage in human sepsis, even if its 
effect has been evaluated by measuring of serum 
S100B, which is not a reliable marker of SAE, like 
previously reported (25). 
A more precise knowledge of pathophysiology of 
SAE will open new therapeutic perspective [26-33]. 
Conclusions 
Pathogenesis of SAE is multifactorial and it's 
arduous to exclude an interplay between the toxic 
mediators involved in sepsis and the indirect effect of 
hypertermia, hypoperfusion and hypoxia. 
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Diagnosis of SAE is primary clinical, and there is no 
specific test. The role of S100B is not clear but its 
increase in serum is very probably of extracerebral 
origin and does not prove an injury of the BBB. 
Anyway the possibility that BBB damage is an 
important contributor of SAE deserves high regard. 
SAE is reversible, but it can negatively influence the 
prognosis in septic patients. 
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